St. Jude Cloud offers the world's largest public repository of
pediatric cancer genomics data alongside unique analysis and visualization tools.
Not exact matches
«Incorporating
genomic sequencing, counseling into
pediatric cancer treatment shows benefit.»
They elaborate on several focus areas described by the White House earlier: preventive vaccines, early detection, single
cancer cell
genomics, immunotherapy,
pediatric cancer, and data sharing.
Currently, a
genomic analysis clinical trial at the
Cancer Institute is focused on those patients with rare or poor - prognosis
cancers, including
pediatric patients.
Dr. Cole's research interests include
cancer genomics and the identification of molecularly targeted therapies for
pediatric malignancies.
«Recent research shows that more potential targets are being identified through
genomic analysis for
pediatric cancers.
Researchers leading the largest
genomic tumor profiling effort of its kind say such studies are technically feasible in a broad population of adult and
pediatric patients with many different types of
cancer, and that some patients can benefit by receiving precision drugs targeted to their tumors» mutations or being enrolled in clinical trials.
This new commitment to the precision medicine initiative will provide additional opportunities over the next three years for physicians to analyze the
genomic profiles of
pediatric patients to better understand their
cancers and help improve treatment options.
Recognizing a need to further explore
genomic profiling in
pediatric malignancies, the Hugs for Brady Foundation has committed $ 300,000 to the precision medicine initiative at Rutgers
Cancer Institute of New Jersey.
This supports the idea that
genomic profiling should be a routine part of
pediatric cancer care.
My studies of
cancer genomes have led to characterization of multiple
pediatric and adult tumor types, to development of methods that identify and characterize changes in
genomic heterogeneity, to defining acquired resistance mechanisms to targeted therapies and to designing novel, personalized vaccines for individual patients.
Our groundbreaking
Pediatric Mi - Oncoseq Program is an internationally known precision oncology program focusing on the genetic analysis of
pediatric cancer patients including in children with malignant brain tumors, and determines whether targeted treatments may be available based upon their personalized tumor
genomic sequencing profiles.
Topics that will be explored include: • Cellular and developmental origins of
pediatric cancer • Key findings of pan-
cancer analysis efforts • Computational pipelines to analyze large - scale sequencing data • Opportunities for leveraging existing
cancer genomics datasets • Strategies for integrative analysis of germline and somatic variants • Correlation of germline / somatic variation to clinical features such as tumor subtype.
August 15, 2017 New
genomic data platform to focus on children's health issues UChicago Medicine to play key role in NIH - funded initiative that concentrates on genetic flaws related to
pediatric cancer, birth defects